These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

325 related items for PubMed ID: 31425688

  • 1. Acute L-DOPA administration reverses changes in firing pattern and low frequency oscillatory activity in the entopeduncular nucleus from long term L-DOPA treated 6-OHDA-lesioned rats.
    Aristieta A, Ruiz-Ortega JA, Morera-Herreras T, Miguelez C, Ugedo L.
    Exp Neurol; 2019 Dec; 322():113036. PubMed ID: 31425688
    [Abstract] [Full Text] [Related]

  • 2. Chronic L-DOPA administration increases the firing rate but does not reverse enhanced slow frequency oscillatory activity and synchronization in substantia nigra pars reticulata neurons from 6-hydroxydopamine-lesioned rats.
    Aristieta A, Ruiz-Ortega JA, Miguelez C, Morera-Herreras T, Ugedo L.
    Neurobiol Dis; 2016 May; 89():88-100. PubMed ID: 26852950
    [Abstract] [Full Text] [Related]

  • 3. Coherence of neuronal firing of the entopeduncular nucleus with motor cortex oscillatory activity in the 6-OHDA rat model of Parkinson's disease with levodopa-induced dyskinesias.
    Jin X, Schwabe K, Krauss JK, Alam M.
    Exp Brain Res; 2016 Apr; 234(4):1105-18. PubMed ID: 26724931
    [Abstract] [Full Text] [Related]

  • 4. Effect of subthalamic nucleus or entopeduncular nucleus lesion on levodopa-induced neurochemical changes within the basal ganglia and on levodopa-induced motor alterations in 6-hydroxydopamine-lesioned rats.
    Périer C, Marin C, Jimenez A, Bonastre M, Tolosa E, Hirsch EC.
    J Neurochem; 2003 Sep; 86(6):1328-37. PubMed ID: 12950442
    [Abstract] [Full Text] [Related]

  • 5. l-dopa-induced dyskinesias in unilateral 6-hydroxydopamine-lesioned rats are not modified by excitotoxic lesion of the entopeduncular nucleus and substantia nigra pars reticulata.
    Gago B, Marin C, Rodríguez-Oroz MC, Obeso JA.
    Synapse; 2013 Jul; 67(7):407-14. PubMed ID: 23404474
    [Abstract] [Full Text] [Related]

  • 6. Buspirone requires the intact nigrostriatal pathway to reduce the activity of the subthalamic nucleus via 5-HT1A receptors.
    Sagarduy A, Llorente J, Miguelez C, Morera-Herreras T, Ruiz-Ortega JA, Ugedo L.
    Exp Neurol; 2016 Mar; 277():35-45. PubMed ID: 26687972
    [Abstract] [Full Text] [Related]

  • 7. Alterations in the expression of nNOS in the substantia nigra and subthalamic nucleus of 6-OHDA-lesioned rats: the effects of chronic treatment with l-DOPA and the nitric oxide donor, molsidomine.
    Czarnecka A, Lenda T, Domin H, Konieczny J, Smiałowska M, Lorenc-Koci E.
    Brain Res; 2013 Dec 06; 1541():92-105. PubMed ID: 24129225
    [Abstract] [Full Text] [Related]

  • 8. Bilateral subthalamic nucleus lesion reverses L-dopa-induced motor fluctuations and facilitates dyskinetic movements in hemiparkinsonian rats.
    Marin C, Jiménez A, Tolosa E, Bonastre M, Bové J.
    Synapse; 2004 Feb 06; 51(2):140-50. PubMed ID: 14618681
    [Abstract] [Full Text] [Related]

  • 9. Autoradiographic labelling of metabotropic glutamate type 2/3 receptors in the hemi-parkinsonian rat brain.
    Kim E, Frouni I, Shaqfah J, Bédard D, Huot P.
    J Chem Neuroanat; 2024 Jul 06; 138():102422. PubMed ID: 38657828
    [Abstract] [Full Text] [Related]

  • 10. NMDA receptor antagonism potentiates the L-DOPA-induced extracellular dopamine release in the subthalamic nucleus of hemi-parkinson rats.
    El Arfani A, Bentea E, Aourz N, Ampe B, De Deurwaerdère P, Van Eeckhaut A, Massie A, Sarre S, Smolders I, Michotte Y.
    Neuropharmacology; 2014 Oct 06; 85():198-205. PubMed ID: 24863042
    [Abstract] [Full Text] [Related]

  • 11. Effect of deep brain stimulation on levodopa-induced dyskinesias and striatal oscillatory local field potentials in a rat model of Parkinson's disease.
    Alam M, Capelle HH, Schwabe K, Krauss JK.
    Brain Stimul; 2014 Oct 06; 7(1):13-20. PubMed ID: 24126192
    [Abstract] [Full Text] [Related]

  • 12. The effect of 5-HT1A receptor agonists on the entopeduncular nucleus is modified in 6-hydroxydopamine-lesioned rats.
    Vegas-Suárez S, Aristieta A, Requejo C, Bengoetxea H, Lafuente JV, Miguelez C, Ugedo L.
    Br J Pharmacol; 2021 Jun 06; 178(12):2516-2532. PubMed ID: 33686657
    [Abstract] [Full Text] [Related]

  • 13. L-DOPA-induced dyskinesia in adult rats with a unilateral 6-OHDA lesion of dopamine neurons is paralleled by increased c-fos gene expression in the subthalamic nucleus.
    Soghomonian JJ.
    Eur J Neurosci; 2006 May 06; 23(9):2395-403. PubMed ID: 16706847
    [Abstract] [Full Text] [Related]

  • 14. Increased slow oscillatory activity in substantia nigra pars reticulata triggers abnormal involuntary movements in the 6-OHDA-lesioned rat in the presence of excessive extracellular striatal dopamine.
    Meissner W, Ravenscroft P, Reese R, Harnack D, Morgenstern R, Kupsch A, Klitgaard H, Bioulac B, Gross CE, Bezard E, Boraud T.
    Neurobiol Dis; 2006 Jun 06; 22(3):586-98. PubMed ID: 16531050
    [Abstract] [Full Text] [Related]

  • 15. Abnormal Cortico-Basal Ganglia Neurotransmission in a Mouse Model of l-DOPA-Induced Dyskinesia.
    Dwi Wahyu I, Chiken S, Hasegawa T, Sano H, Nambu A.
    J Neurosci; 2021 Mar 24; 41(12):2668-2683. PubMed ID: 33563724
    [Abstract] [Full Text] [Related]

  • 16. Globus pallidus, but not entopeduncular nucleus, 6-OHDA-induced lesion attenuates L-Dopa-induced dyskinesia in the rat model of Parkinson's disease.
    Marin C, Bonastre M, Fuentes M, Mullol J.
    Pharmacol Biochem Behav; 2020 Oct 24; 197():173013. PubMed ID: 32758524
    [Abstract] [Full Text] [Related]

  • 17. 5-Hydroxy-tryptophan for the treatment of L-DOPA-induced dyskinesia in the rat Parkinson's disease model.
    Tronci E, Lisci C, Stancampiano R, Fidalgo C, Collu M, Devoto P, Carta M.
    Neurobiol Dis; 2013 Dec 24; 60():108-14. PubMed ID: 24004632
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Neurotoxic effects of berberine on long-term L-DOPA administration in 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
    Shin KS, Choi HS, Zhao TT, Suh KH, Kwon IH, Choi SO, Lee MK.
    Arch Pharm Res; 2013 Jun 24; 36(6):759-67. PubMed ID: 23539311
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.